Aarti Drugs Ltd.
| BSE: 524348 | Sector: Health care |
| NSE: AARTIDRUGS | ISIN Code: INE767A01016 |
| BSE 00:00 | 12 May | 797.20 |
-14.65 (-1.80%) |
OPEN
812.00 |
HIGH
822.00 |
LOW
789.30 |
| NSE 00:00 | 12 May | 798.30 |
-13.35 (-1.64%) |
OPEN
811.00 |
HIGH
821.95 |
LOW
790.25 |
| OPEN | 812.00 |
| PREVIOUS CLOSE | 811.85 |
| VOLUME | 105589 |
| 52-Week high | 1025.00 |
| 52-Week low | 187.50 |
| P/E | 28.81 |
| Mkt Cap.(Rs cr) | 7,430 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Aarti Drugs Ltd. (AARTIDRUGS) - News Sector
-
Nifty Pharma index hits all-time high; Sun Pharma scales 4-year high
12.24 pm | 10 May 2021 | Business Standard
Since April, the Nifty Pharma index has outperformed the market by surging 15 per cent, against 1.7 per cent gain in the Nifty50 index
-
Nifty Pharma index hits all-time high; Sun Pharma scales 4-year high
12.24 pm | 10 May 2021 | Business Standard
Since April, the Nifty Pharma index has outperformed the market by surging 15 per cent, against 1.7 per cent gain in the Nifty50 index
-
Nifty Pharma index hits all-time high; Sun Pharma scales 4-year high
12.24 pm | 10 May 2021 | Business Standard
Since April, the Nifty Pharma index has outperformed the market by surging 15 per cent, against 1.7 per cent gain in the Nifty50 index
-
Nifty Pharma index hits all-time high; Sun Pharma scales 4-year high
12.24 pm | 10 May 2021 | Business Standard
Since April, the Nifty Pharma index has outperformed the market by surging 15 per cent, against 1.7 per cent gain in the Nifty50 index
-
Nifty Pharma index hits all-time high; Sun Pharma scales 4-year high
12.24 pm | 10 May 2021 | Business Standard
Since April, the Nifty Pharma index has outperformed the market by surging 15 per cent, against 1.7 per cent gain in the Nifty50 index
-
Nifty Pharma index hits all-time high; Sun Pharma scales 4-year high
12.24 pm | 10 May 2021 | Business Standard
Since April, the Nifty Pharma index has outperformed the market by surging 15 per cent, against 1.7 per cent gain in the Nifty50 index
-
Nifty Pharma index hits all-time high; Sun Pharma scales 4-year high
12.24 pm | 10 May 2021 | Business Standard
Since April, the Nifty Pharma index has outperformed the market by surging 15 per cent, against 1.7 per cent gain in the Nifty50 index
-
Nifty Pharma index hits all-time high; Sun Pharma scales 4-year high
12.24 pm | 10 May 2021 | Business Standard
Since April, the Nifty Pharma index has outperformed the market by surging 15 per cent, against 1.7 per cent gain in the Nifty50 index
-
Amid supply crunch, private hospitals eyeing import of Covid-19 vaccines
10.39 pm | 7 May 2021 | Business Standard
Two major hospital groups, Apollo Hospitals and Fortis Healthcare, said they are open to exploring opportunities to import
-
Amid supply crunch, private hospitals eyeing import of Covid-19 vaccines
10.39 pm | 7 May 2021 | Business Standard
Two major hospital groups, Apollo Hospitals and Fortis Healthcare, said they are open to exploring opportunities to import
-
India's pharma market rebounds in April, clocks 51.5% sales growth
10.06 pm | 7 May 2021 | Business Standard
Low base of April 2020, pick-up in demand for Covid-19 drugs major contributors to growth
-
India's pharma market rebounds in April, clocks 51.5% sales growth
10.06 pm | 7 May 2021 | Business Standard
Low base of April 2020, pick-up in demand for Covid-19 drugs major contributors to growth
-
India's pharma market rebounds in April, clocks 51.5% sales growth
10.06 pm | 7 May 2021 | Business Standard
Low base of April 2020, pick-up in demand for Covid-19 drugs major contributors to growth
-
Anupam Rasayan rallies 13% in 2 days after Plutus Wealth buys stake
12.32 pm | 6 May 2021 | Business Standard
On May 5, Plutus Wealth Management purchased 1 million shares, representing 1 per cent stake of Anupam Rasayan India, for Rs 64.75 crore
-
Lupin soars 8%, hits over three-year high on heavy volumes
11.33 am | 5 May 2021 | Business Standard
The stock surpassed its previous high of Rs 1,121.85 touched on September 2020 and was trading at the highest level since July 2017
-
Alembic Pharma falls 6% post March quarter results
10.04 am | 5 May 2021 | Business Standard
Alembic Pharma Q4FY21 operational performance was marginally below estimates, largely due to lower traction in US and Domestic Formulation (DF) sales
-
Hikal hits new high on signing 10-year deal with global pharma Co
9.36 am | 5 May 2021 | Business Standard
This contract entails the development and supply of a portfolio of niche APIs (Active Pharmaceutical Ingredient) over a period of 10 years
-
Nifty close below 14,416 would be bearish for short-term: Vinay Rajani
8.28 am | 5 May 2021 | Business Standard
Below 14,416, Nifty could slide towards next support of 14,150
-
Pricing pressure in US market to impact margins of pharma companies
11.48 pm | 4 May 2021 | Business Standard
Lack of new launches due to inspection delays, intensifying competition key headwinds
-
Alembic Pharma Q4 net up 12% to Rs 251 cr on strong API, global businesses
8.24 pm | 4 May 2021 | Business Standard
Net sales rise 6% to Rs 1,280 cr; API business expands by as much as 38%
Quick Links for Aarti Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
